Invention Grant
- Patent Title: Anti-Tim-3 antibodies
-
Application No.: US15679190Application Date: 2017-08-17
-
Publication No.: US10253096B2Publication Date: 2019-04-09
- Inventor: Yi Zhang , Yang Shen , Carmine Carpenito , Yiwen Li
- Applicant: Eli Lilly and Company
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Robert Brian Johnson
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K45/06 ; A61K39/395 ; A61N5/10 ; C12N5/10 ; A61K39/00
Abstract:
The present invention relates to antibodies that bind human T-cell immunoglobulin- and mucin-domain-containing protein-3 (Tim-3), and may be useful for treating solid and hematological tumors alone and in combination with chemotherapy and ionizing radiation.
Public/Granted literature
- US20180057591A1 ANTI-TIM-3 ANTIBODIES Public/Granted day:2018-03-01
Information query
